<- Go Home

Bonesupport Holding AB (publ)

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Market Cap

SEK 15.5B

Volume

255.2K

Cash and Equivalents

SEK 434.3M

EBITDA

SEK 311.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

SEK 1.2B

Profit Margin

92.05%

52 Week High

SEK 273.20

52 Week Low

SEK 165.00

Dividend

N/A

Price / Book Value

16.45

Price / Earnings

73.93

Price / Tangible Book Value

16.72

Enterprise Value

SEK 15.1B

Enterprise Value / EBITDA

47.23

Operating Income

SEK 309.4M

Return on Equity

24.50%

Return on Assets

18.58

Cash and Short Term Investments

SEK 434.3M

Debt

SEK 10.1M

Equity

SEK 949.7M

Revenue

SEK 1.3B

Unlevered FCF

SEK 158.7M

Sector

Biotechnology

Category

N/A

Company Stock Pitches